Hypertension Disparities in African Americans: Stats & Policy
This paper examines hypertension disparities affecting African Americans, situating the issue within the broader context of health disparities faced by minority and socially disadvantaged populations. Drawing on the Jackson Heart Study and peer-reviewed literature, it reviews prevalence statistics, racial differences in blood pressure control, and the heightened risks of stroke, heart failure, and kidney disease in African American communities. The paper then evaluates evidence-based interventions—particularly team-based care and culturally tailored patient programs—and concludes with policy recommendations including reduced out-of-pocket costs, value-based insurance design, and the integration of hypertension control into existing state and local public health frameworks.
- Introduction: Defines health disparities and hypertension basics
- Identifying the Statistics: Jackson Heart Study blood pressure control data
- Current Literature on Racial Disparities: Racial gaps in hypertension prevalence and outcomes
- Interventions for Hypertension Control: Team-based and culturally tailored intervention strategies
- Policy Approaches and Recommendations: Insurance design and population-level policy levers
- Conclusion: Summary of multi-level response needed
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- It grounds abstract disparity claims in concrete quantitative data from the Jackson Heart Study, making arguments measurable and credible.
- It moves logically from problem definition to evidence review to intervention strategies to policy recommendations, giving the paper a clear applied-health structure.
- Racial risk comparisons (e.g., stroke mortality twice as high, end-stage kidney disease five times as prevalent) are cited with specific figures, strengthening rhetorical impact.
- It connects individual-level interventions (community health workers, culturally based programs) with systems-level policy levers (VBID, out-of-pocket cost reduction), demonstrating multi-level thinking.
Key academic technique demonstrated
The paper demonstrates evidence synthesis across multiple source types—epidemiological studies, clinical trial data, government reports, and policy analyses—to build a cumulative case. Rather than treating each source in isolation, the author layers statistics, clinical findings, and policy evidence to show that hypertension disparities require coordinated responses at the individual, community, and systems levels.
Structure breakdown
The paper opens with a conceptual framing of health disparities and hypertension, then moves into quantitative statistics from the Jackson Heart Study. A literature review covers racial differences in prevalence, medication use, and organ damage risk. Two applied sections follow—one on team-based and culturally tailored interventions, one on insurance and population-based policy—before a brief concluding synthesis. The structure mirrors a standard public health policy brief format.
Introduction
Health disparities refer to avoidable differences in the occurrence of violence, disease, and injury, or in the opportunities for enjoying peak health, faced by minority and socially disadvantaged ethnic and racial populations and communities. Health differences are present across every age group, including older adults. Although general health and life expectancy have both improved in recent decades, the Centers for Disease Control and Prevention (CDC) recognizes that not every senior adult benefits equally from these gains, due to factors such as race, economic status, and gender. The CDC acknowledges that this issue is a growing concern and has integrated it into its core responsibilities (Centers for Disease Control and Prevention, 2015).
Hypertension, commonly called high blood pressure (HBP), is a medical condition in which blood flows through the vessels with greater-than-normal force. When the heart beats, it drives blood through the arteries to other parts of the body. When the pumped blood presses too hard against the arterial wall, blood pressure rises. A person's blood pressure varies throughout the day — it is typically higher after exercise, upon waking in the morning, or during periods of stress. Hypertension can overwork the heart, rupture blood vessels, and raise the risk of stroke, heart attack, kidney disease, and death (Pcori, 2013).
Identifying the Statistics
The hypertension treatment regimens used by adult African Americans within the Jackson Heart Study were analyzed during the first two medical examinations — 2,415 participants at Exam I (2000–2004) and 2,577 at Exam II (2005–2008). Blood pressure (BP) readings were below 140/90 mm Hg for 66% and 70% of participants at Exam I and Exam II respectively; JNC7 BP treatment objectives were achieved for 56% and 61% at Exam I and Exam II respectively. Participants living with chronic kidney disease (CKD) or diabetes were less likely to have BP at the target level. Similarly, men were less likely than women to meet target BP. The most frequently used antihypertensive medications were thiazide diuretics, and participants taking these drugs had higher rates of BP regulation than those who were not. Thiazide use was notably lower among men than women. Although calcium channel blockers are generally considered an effective single therapy for African Americans, participants using this therapy were less likely to be at target BP compared to those on thiazide single therapy (Harman et al., 2013).
Current Literature on Racial Disparities
The prevalence of hypertension among African Americans is among the highest in the world, and because this population is more likely to control the condition poorly, they frequently suffer target-organ damage. Among African Americans living with hypertension who develop heart failure, hypertension is often found to be poorly controlled. Nonetheless, even after adjusting for risk factors and blood pressure regulation, African Americans remain at elevated risk for heart problems, especially heart failure (Sharma, Colvin-Adams, & Yancy, 2014).
Hypertension in African Americans demands intensive examination and aggressive treatment. Antihypertensive drugs must be prescribed in a timely manner, and the risk of reduced treatment effectiveness with drug combinations is a concern because most hypertensive patients require more than one medication. A significant debate continues regarding the appropriate blood pressure thresholds for diagnosing hypertension and the optimal target BPs for African Americans. The 2014 National Committee report recommends 140/90 mm Hg as the hypertension treatment target for all patients except older adults, for whom 150/90 mm Hg is considered appropriate. The same targets apply to African Americans. Previous recommendations from this committee included thiazide diuretics as the first-line antihypertensive therapy for African Americans; more recent recommendations added calcium channel blockers as an alternative. However, for those with left ventricular systolic dysfunction, hypertension treatment should include medications that reduce the risk of death from heart failure — specifically nitrates, angiotensin-converting enzyme (ACE) inhibitors, aldosterone receptor antagonists, and beta-blockers (Sharma, Colvin-Adams, & Yancy, 2014).
Racial differences in hypertension and its related conditions are well documented, including the higher mortality risk among African Americans compared to white Americans. These elevated BP risks have a marked effect on life expectancy: the life expectancy of African Americans is considerably lower than that of Caucasian Americans. The risk of stroke mortality is twice as high in African Americans. The risk of end-stage kidney disease is five times greater. Moreover, the age at which conditions such as stroke occur is significantly earlier among African Americans. For example, an African American man aged 45 living in the Southeast faces the same stroke risk as a white man aged 55 in the Southeast and a white man aged 65 in the Midwest. Although high blood pressure is a widespread problem, it is more prevalent in the African American population. This higher prevalence generates substantial population-attributable risks: the specific population-attributable risk for 30-year mortality linked to hypertension was 23.8% for white males versus 45.2% for Black males, and 18.3% for white females versus 39.5% for Black females (Lackland, 2014).
Conclusion
Hypertension disparities among African Americans represent a serious and persistent public health challenge. Addressing them requires coordinated action across clinical, community, and policy levels. The evidence reviewed here demonstrates that African Americans face disproportionately high rates of hypertension and its complications, including stroke, heart failure, and kidney disease. Team-based care and culturally tailored self-management interventions offer promising pathways for improving blood pressure control at the individual and community levels. At the same time, policy measures such as reducing out-of-pocket costs and implementing value-based insurance design can enhance medication adherence and treatment access. Integrating hypertension control into existing state and local public health programs, while ensuring that these programs are adapted to meet the needs of high-risk populations, is essential for achieving meaningful and lasting reductions in these disparities.
Create your account
Always verify citation format against your institution’s current style guide requirements.